Rafael Holdings Inc stock is traded at $1.06, with a volume of 92,620. It is down -0.93% in the last 24 hours and down -27.89% over the past month. Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
Previous Close:
$1.07
Open:
$1.10
24h Volume:
92,620
Relative Volume:
1.17
Market Cap:
$55.32M
Revenue:
$1.16M
Net Income/Loss:
-$32.23M
P/E Ratio:
-
EPS:
-$0.785
Net Cash Flow:
-$27.90M
1W Performance:
-5.36%
1M Performance:
-27.89%
6M Performance:
-16.54%
1Y Performance:
-20.30%
1-Day Range:
$1.05$1.20
1-Week Range:
$0.9928$1.20
52-Week Range:
$0.9928$3.96
Rafael Holdings Inc Stock (RFL) Company Profile
Name
Rafael Holdings IncSector
Real EstateIndustry
Real Estate ServicesPhone
212-658-1450Address
520 BROAD STREET, NEWARK, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS